JPH0215097A - ゴナドリベリン誘導体含有薬剤の製造方法及びその使用方法 - Google Patents

ゴナドリベリン誘導体含有薬剤の製造方法及びその使用方法

Info

Publication number
JPH0215097A
JPH0215097A JP1115265A JP11526589A JPH0215097A JP H0215097 A JPH0215097 A JP H0215097A JP 1115265 A JP1115265 A JP 1115265A JP 11526589 A JP11526589 A JP 11526589A JP H0215097 A JPH0215097 A JP H0215097A
Authority
JP
Japan
Prior art keywords
group
derivative
general formula
drug
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP1115265A
Other languages
English (en)
Japanese (ja)
Inventor
Gyoergy Keri
ジェルジ　ケーリ
Robert I Nicholson
ロバート　アイ　ニコルソン
Istvan Teplan
イシュトワーン　テプラーン
Tamas Gulyas
タマーシュ　グイヤーシュ
Aniko Horvath
アニコー　ホルヴァート
Gyoergy Boekoenyi-Nee-Major
ジェルジ　ベケーニュイ　ネーエ　マヨル
Balazs Szoeke
バラーズ　セーケ
Agnes Balogh
アグネシュ　バロフ
Orsolya Csuka
オルソイヤ　チュカ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Innofinance Altalanos Innovacios Penzintezet
Original Assignee
Innofinance Altalanos Innovacios Penzintezet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innofinance Altalanos Innovacios Penzintezet filed Critical Innofinance Altalanos Innovacios Penzintezet
Publication of JPH0215097A publication Critical patent/JPH0215097A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
JP1115265A 1988-05-10 1989-05-10 ゴナドリベリン誘導体含有薬剤の製造方法及びその使用方法 Pending JPH0215097A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU2251-2347/88 1988-05-10
HU882347A HU199694B (en) 1988-05-10 1988-05-10 Process for producing citostatic pharmaceutical compositions containing gonadoliberin derivatives

Publications (1)

Publication Number Publication Date
JPH0215097A true JPH0215097A (ja) 1990-01-18

Family

ID=10958948

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1115265A Pending JPH0215097A (ja) 1988-05-10 1989-05-10 ゴナドリベリン誘導体含有薬剤の製造方法及びその使用方法

Country Status (16)

Country Link
JP (1) JPH0215097A (fr)
KR (1) KR900017610A (fr)
BE (1) BE1004932A3 (fr)
CH (1) CH678013A5 (fr)
DE (1) DE3915317A1 (fr)
DK (1) DK228289A (fr)
FI (1) FI892275A7 (fr)
FR (1) FR2631237A1 (fr)
GB (1) GB2218335B (fr)
GR (1) GR890100315A (fr)
HU (1) HU199694B (fr)
IL (1) IL89998A0 (fr)
IT (1) IT1229251B (fr)
LU (1) LU87516A1 (fr)
NL (1) NL8901159A (fr)
SE (1) SE8901660L (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5760000A (en) * 1994-05-13 1998-06-02 University Technologies International,Inc. Inhibition of liver cancer by the use of GnRH and GnRH analogs
US6054432A (en) * 1996-09-12 2000-04-25 Asta Medica Aktiengesellschaft Means for treating prostate hypertrophy and prostate cancer

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4410514A (en) * 1982-12-06 1983-10-18 The Salk Institute For Biological Studies GnRH Agonists
IT1178775B (it) * 1983-12-23 1987-09-16 Konzponti Valto Es Hitelbank R Derivati della gonadoliberina e procedimento per la loro preparazione
HU189394B (en) * 1983-12-23 1986-06-30 Koezponti Valto- Es Hitelbank Rt Innovacios Alap,Hu Method for producing spermatozoa suitable for fertilization from mature fishes
US4760053A (en) * 1984-08-02 1988-07-26 Fernand Labrie Combination therapy for selected sex steroid dependent cancers
WO1986001105A1 (fr) * 1984-08-02 1986-02-27 Fernand Labrie Composition pharmaceutique pour le traitement de cancers dependant d'hormones
HU193607B (en) * 1985-07-18 1987-11-30 Innofinance Altalanos Innovaci Process for production of sexual products applyable for natural or artificial insemination for mammates
US4721775A (en) * 1985-08-26 1988-01-26 Board Of Regents, The University Of Texas System Effective peptides related to the luteinizing hormone releasing hormone from L-amino acids
HU194913B (en) * 1986-01-03 1988-03-28 Innofinance Altalanos Innovaci Process for producing novel gonadoliberin derivatives containing in the sixth position aromatic amino carboxylic acid and medical preparations containing these compounds

Also Published As

Publication number Publication date
HU199694B (en) 1990-03-28
IT1229251B (it) 1991-07-26
GB2218335A (en) 1989-11-15
FI892275A0 (fi) 1989-05-10
SE8901660D0 (sv) 1989-05-10
GB8910724D0 (en) 1989-06-28
HUT49813A (en) 1989-11-28
NL8901159A (nl) 1989-12-01
BE1004932A3 (fr) 1993-03-02
KR900017610A (ko) 1990-12-19
IL89998A0 (en) 1989-12-15
CH678013A5 (fr) 1991-07-31
DK228289D0 (da) 1989-05-10
SE8901660L (sv) 1989-11-11
IT8920435A0 (it) 1989-05-11
GB2218335B (en) 1991-09-25
FR2631237A1 (fr) 1989-11-17
GR890100315A (el) 1990-03-12
FI892275A7 (fi) 1989-11-11
DE3915317A1 (de) 1989-11-23
LU87516A1 (fr) 1990-12-11
DK228289A (da) 1989-11-11

Similar Documents

Publication Publication Date Title
Meites et al. Hypothalamic control of prolactin secretion
Schally et al. Somatostatin analogs as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer.
Lin et al. Effects of [d-Arg6, Trp7, Leu8, Pro9 NEt]-luteinizing hormone-releasing hormone (sGnRH-A) and [d-Ala6, Pro9NEt]-luteinizing hormone-releasing hormone (LHRH-A), in combination with pimozide or domperidone, on Gonadotropin release and ovulation in the Chinese loach and common carp
Meites Aging: hypothalamic catecholamines, neuroendocrine-immune interactions, and dietary restriction
Jungwirth et al. Luteinizing hormone‐releasing hormone antagonist Cetrorelix (SB‐75) and bombesin antagonist RC‐3940‐II inhibit the growth of androgen‐independent PC‐3 prostate cancer in nude mice
Taylor et al. Testosterone in a cyclodextrin-containing formulation: behavioral and physiological effects of episode-like pulses in rats
Millar, RP, King, JA, Davidson, JS & Milton Gonadotrophin-releasing hormone-diversity of functions and clinical applications
Foekens et al. Combined effects of buserelin, estradiol and tamoxifen on the growth of MCF-7 human breast cancer cells in vitro
Doherty et al. Increased serum prolactin levels mediate the suppressive effects of ectopic pituitary grafts on copulatory behavior in male rats
Ahluwalia et al. Effects of exogenous hormones on the male reproductive organs of vitamin A-deficient rats
RU2418604C9 (ru) Способ регулирования фолликулярного резерва яичника, способ лечения отклонений в росте покоящихся фолликулов у женщин, средство стимуляции развития фолликулов и средство определения влияния соединений на ускорение или замедление роста фолликулов при проведении токсикологических испытаний (варианты)
Desjardins et al. Anterior pituitary levels of FSH, LH, ACTH and prolactin after mating in female rabbits.
Smith Jr et al. Testicular histology after prolonged treatment with a gonadotropin-releasing hormone analogue
JPH0215097A (ja) ゴナドリベリン誘導体含有薬剤の製造方法及びその使用方法
Korkut et al. Inhibition of growth of experimental prostate cancer with sustained delivery systems (microcapsules and microgranules) of the luteinizing hormone-releasing hormone antagonist SB-75.
Schally et al. Combination of a long-acting delivery system for luteinizing hormone-releasing hormone agonist with Novantrone chemotherapy: increased efficacy in the rat prostate cancer model.
Tisell Effect of cortisone on the growth of the ventral prostate, the dorsolateral prostate, the coagulating glands and the seminal vesicles in castrated adrenalectomized and castrated non-adrenalectomized rats
Götze et al. Anti-oestrogenic effects of tamoxifen on mammary gland and hypophysis in female rats
HILLIARD et al. Luteotrophic and luteolytic actions of LH in hypophysectomized, pseudopregnant rabbits
Lamberts et al. The effect of the somatostatin analog SMS 201-995 on normal growth hormone secretion in the rat.
Evans et al. Mechanisms for hypogonadism in hyperprolactinemia
Tominaga et al. Effect of CGS 16949A plus tamoxifen on induced mammary tumours in rats
Gibson et al. Regulation of estrogen-binding capacity by insulin in 7, 12-dimethylbenz (a) anthracene-induced mammary tumors in rats
Brooks et al. Inhibition of mammary dysplasia in estrogen-treated C3H/HeJ female mice by treatment with 2-bromo-α-ergocryptine
FRIEDEN The effects of estrogen and relaxin upon the uptake of glycine-1-C14 by connective tissue in vivo